Endocannabinoids alleviate proinflammatory conditions by modulating innate immune response in muller glia during inflammation

GLIA

Volumn 60, Issue 11, 2012, Pages 1629-1645

  Krishnan, Gopinath ^a,b   Chatterjee, Nivedita ^a  

^a VISION RESEARCH FOUNDATION   (India)

^b SASTRA UNIVERSITY   (India)

Author keywords

Cytokines; Endogenous cannabinoids; Neuroprotection; Retina

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; COLONY STIMULATING FACTOR 1; ENDOCANNABINOID; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1 BINDING PROTEIN 1; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; PROTEIN KINASE B; REGULATOR PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRISTETRAPROLIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL DEATH; CELL SURVIVAL; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GLIA; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INNATE IMMUNITY; MUELLER CELL; NEUROPROTECTION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ARACHIDONIC ACIDS; CANNABINOID RECEPTOR AGONISTS; CELLS, CULTURED; CYTOKINES; ENDOCANNABINOIDS; GLYCERIDES; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; NEUROGLIA; PHOSPHORYLATION; POLYUNSATURATED ALKAMIDES; RETINA; TRISTETRAPROLIN;

EID: 84865843840     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22380     Document Type: Article

References (70)

1. Benito C, Romero JP, Tolón RM, Clemente D, Docagne F, Hillard CJ. 2007. Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis. J Neurosci 27: 2396-2402.
2. Berdyshev EV, Boichot E, Germain N, Allain N, Anger JP, Lagente V. 1997. Influence of fatty acid ethanolamides and delta9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells. Eur J Pharmacol 330: 231-240.
3. Bhattacharyya S, Sen P, Wallet M, Long B, Baldwin AS Jr, Tisch R. 2004. Immunoregulation of dendritic cells by IL-10 is mediated through suppression of the PI3K/Akt pathway and of IkappaB kinase activity. Blood 104: 1100-1109.
4. Boeuf P, Vigan-Womas I, Jublot D, Loizon S, Barale JC, Akanmori BD, Mercereau-Puijalon O, Behr C. 2005. CyProQuant-PCR: A real time RT-PCR technique for profiling human cytokines, based on external RNA standards, readily automatable for clinical use. BMC Immunol 6: 5.
5. Bringmann A, Iandiev I, Pannicke T, Wurm A, Hollborn M, Wiedemann P, Osborne NN, Reichenbach A. 2009. Cellular signalling and factors involved in Müller cell gliosis: Neuroprotective and detrimental effects. Prog Retin Eye Res 28: 423-451.
6. Bringmann A, Pannicke T, Grosche J, Francke M, Wiedemann P, Skatchkov SN, Osborne NN, Reichenbach A. 2006. Müller cells in the healthy and diseased retina. Prog Retin Eye Res 25: 397-424.
7. Cao S, Liu J, Chesi M, Bergsagel PL, Ho IC, Donnelly RP, Ma X. 2002. Differential regulation of IL-12 and IL-10 gene expression in macrophages by the basic leucine zipper transcription factor c-Maf fibrosarcoma. J Immunol 169: 5715-5725.
8. Carballo E, Lai WS, Blackshear PJ. 1998. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281: 1001-1005.
9. Carter AB, Hunninghake GW. 2000. A constitutive active MEK --> ERK pathway negatively regulates NF-kappa B-dependent gene expression by modulating TATA-binding protein phosphorylation. J Biol Chem 275: 27858-27864.
10. Cencioni MT, Chiurchiù V, Catanzaro G, Borsellino G, Bernardi G, Battistini L, Maccarrone M. 2010. Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors. PLoS One 5: e8688.
11. Chi H, Barry SP, Roth RJ, Wu JJ, Jones EA, Bennett AM, Flavell RA. 2006. Dynamic regulation of pro- and anti inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc Natl Acad Sci USA 103: 2274-2279.
12. Chiloeches A, Sánchez-Pacheco A, Gil-Araujo B, Aranda A, Lasa M. 2008. Thyroid hormone-mediated activation of the ERK/dual specificity phosphatase 1 pathway augments the apoptosis of GH4C1 cells by down-regulating nuclear factor-kappaB activity. Mol Endocrinol 11: 2466-2480.
13. Clement SL, Scheckel C, Stoecklin G, Lykke-Andersen J. 2011. Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment. Mol Cell Biol 31: 256-266.
14. Conner JR, Smirnova II, Moseman AP, Poltorak A. 2010. IRAK1BP1 inhibits inflammation by promoting nuclear translocation of NF-kappaB p50. Proc Natl Acad Sci USA 107: 11477-11482.
15. Correa F, Hernangómez M, Mestre L, Loría F, Spagnolo A, Docagne F, Di Marzo V, Guaza C. 2010. Anandamide enhances IL-10 production in activated microglia by targeting CB(2) receptors: Roles of ERK1/2, JNK, and NF-kappaB. Glia 58: 135-147.
16. Correa F, Mestre L, Docagne F, Guaza C. 2005. Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages: Role of IL-10 and ERK1/2 kinase signalling. Br J Pharmacol 145: 441-448.
17. Croxford JL, Yamamura T. 2005, Cannabinoids and the immune system: Potential for the treatment of inflammatory diseases? J Neuroimmunol 166: 3-18.
18. De Petrocellis L, Melck D, Palmisano A, Bisogno T, Laezza C, Bifulco M, Di Marzo V. 1998. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc Natl Acad Sci USA 95: 8375-8380.
19. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Piomelli D. 1994. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372: 686-691.
20. Dong C, Davis RJ, Flavell RA. 2002. MAP kinases in the immune response. Annu Rev Immunol 20, 55-72.
21. Eljaschewitsch E, Witting A, Mawrin C, Lee T, Schmidt PM, Wolf S, Hoertnagl H, Raine CS, Schneider-Stock R, Nitsch R, Ullrich O. 2006. The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 49: 67-79.
22. Esposito G, Iuvone T, Savani C, Scuderi C, De Filippis D, Papa M, Di Marzo V, Steardo L. 2007, Opposing control of cannabinoid receptor stimulation on amyloid-beta-induced reactive gliosis: In vitro and in vivo evidence. J Pharmacol Exp Ther 322: 1144-1152.
23. Franklin CC, Kraft AS. 1997. Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J Biol Chem 272: 16917-16923.
24. Gober MD, Fishelevich R, Zhao Y, Unutmaz D, Gaspari AA. 2008, Human natural killer T cells infiltrate into the skin at elicitation sites of allergic contact dermatitis. J Invest Dermatol 128: 1460-1469.
25. Gómez-Nicola D, Valle-Argos B, Pita-Thomas DW, Nieto-Sampedro M. 2008. Interleukin 15 expression in the CNS: Blockade of its activity prevents glial activation after an inflammatory injury. Glia 56: 494-505.
26. Gorina R, Font-Nieves M, Márquez-Kisinousky L, Santalucia T, Planas AM. 2011. Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signalling, MAPK, and Jak1/Stat1 pathways. Glia 59: 242-255.
27. Guha M, Mackman N. 2002. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signalling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem 277: 32124-32132.
28. Hamby ME, Sofroniew MV. 2010. Reactive astrocytes as therapeutic targets for CNS disorders. Neurotherapeutics 7: 494-506.
29. Han KH, Lim S, Ryu J, Lee CW, Kim Y, Kang JH, Kang SS, Ahn YK, Park CS, Kim JJ. 2009. CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages. Cardiovasc Res 84: 378-386.
30. Hirotani T, Lee PY, Kuwata H, Yamamoto M, Matsumoto M, Kawase I, Akira S, Takeda K. 2005. The nuclear IkappaB protein Ikappa BNS selectively inhibits lipopolysaccharide-induced IL-6 production in macrophages of the colonic lamina propria. J Immunol 174: 3650-3657.
31. Chi H, Bennett AM, Flavell RA. 2007. Mitogen-activated protein kinase phosphatase-1 (MKP-1): A critical regulator of innate immune responses. J Organ Dysfunct 3: 72-81.
32. Hu JH, Chen T, Zhuang ZH, Kong L, Yu MC, Liu Y, Zang JW, Ge BX. 2007. Feedback control of MKP-1 expression by p38. Cell Signal 19: 393-400.
33. Huang XX, Yamashiki M, Nakatani K, Nobori T, Mase A. 2001. Semi-quantitative analysis of cytokine mRNA expression induced by the herbal medicine Sho-saiko-to (TJ-9) using a Gel Doc system. J Clin Lab Anal 15: 199-209.
34. Jarvinen T, Pate DW, Laine K. 2002. Cannabinoids in the treatment of glaucoma. Pharmacol Ther 95: 203-220.
35. Johnson TV, Martin KR. 2008. Development and characterization of an adult retinal explant organotypic tissue culture system as an in vitro intraocular stem cell transplantation model. Invest Ophthalmol Vis Sci 49: 3503-3512.
36. Kishimoto S, Kobayashi Y, Oka S, Gokoh M, Waku K, Sugiura T. 2004. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells. J Biochem 135: 517-524.
37. Klein TW. 2005. Cannabinoid-based drugs as anti-inflammatory therapeutics Nat Rev Immunol 5: 400-411.
38. Knect DA, Dimond RL. 1984. Visualization of antigenic proteins on Western blots. Anal Biochem 136: 180-184.
39. Lai WS, Parker JS, Grissom SF, Stumpo DJ, Blackshear PJ. 2006. Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts. Mol Cell Biol 26: 9196-9208.
40. Lambert DM, Fowler CJ. 2005. The endocannabinoid system: Drug targets, lead compounds, and potential therapeutic applications. J Med Chem 48: 5059-5087.
41. Lee HS, Han J, Lee SH, Park JA, Kim KW. 2010. Meteorin promotes the formation of GFAP-positive glia via activation of the Jak-STAT3 pathway. J Cell Sci 123: 1959-1968.
42. Liu Y, Shepherd EG, Nelin LD. 2007. MAPK phosphatases--regulating the immune response. Nat Rev Immunol 7: 202-212.
43. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408.
44. Lu QJ, Straiker A, Lu QX, Maguire G. 2000. Expression of CB2 cannabinoid receptor mRNA in adult rat retina. Visual Neurosci 17: 91-95.
45. Maresz K, Pryce G, Ponomarev ED, Marsicano G, Croxford JL, Shriver LP, Ledent C, Cheng X, Carrier EJ, Mann MK, Giovannoni G, Pertwee RG, Yamamura T, Buckley NE, Hillard CJ, Lutz B, Baker D, Dittel BN. 2007. Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Nat Med 13: 492-497.
46. Matias I, McPartland JM, Di Marzo V. 2005. Occurrence and possible biological role of the endocannabinoid system in the sea squirt Ciona intestinalis. J Neurochem 93: 1141-1156.
47. McGillem GS, Guidry C, Dacheux RF. 1998. Antigenic changes of rabbit retinal Müller cells in culture. Invest Ophthalmol Vis Sci 39: 1453-1461.
48. Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M. 2009. Cannabinoids as novel anti-inflammatory drugs. Future Med Chem 1: 1333-1349.
49. Peterson GL. 1977. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83: 346-356.
50. Pryce G, Ahmed Z, Hankey DJ, Jackson SJ, Croxford JL, Pocock JM, Ledent C, Petzold A, Thompson AJ, Giovannoni G, Cuzner ML, Baker D. 2003. Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain 126: 2191-2202.
51. Puffenbarger RA, Boothe AC, Cabral GA. 2000. Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells. Glia 29: 58-69.
52. Salojin KV, Owusu IB, Millerchip KA, Potter M, Platt KA, Oravecz T. 2006. Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J Immunol 176: 189-907.
53. Sancho R, Calzado MA, Di Marzo V, Appendino G, Munoz E. 2003. Anandamide inhibits nuclear factor-kappaB activation through a cannabinoid receptor-independent pathway. Mol Pharmacol 63: 429-438.
54. Saraiva M, O'Garra A. 2010. The regulation of IL-10 production by immune cells Nat Rev Immunol 10: 170-181.
55. Sawa Y, Ueki T, Hata M, Iwasawa K, Tsuruga E, Kojima H, Ishikawa H, Yoshida S. 2008. LPS-induced IL-6, IL-8, VCAM-1, and ICAM-1 expression in human lymphatic endothelium. J Histochem Cytochem 56: 97-109.
56. Schmittgen TD, Livak KJ 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108.
57. Scotter EL, Abood ME, Glass M. 2010. The endocannabinoid system as a target for the treatment of neurodegenerative disease. Br J Pharmacol 160: 480-498.
58. Shamsuddin N, Kumar A. 2011. TLR2 mediates the innate response of retinal Muller glia to Staphylococcus aureus. J Immunol 186: 7089-7097.
59. Stella N. 2004. Cannabinoid signalling in glial cells. Glia 48: 267-277.
60. Straiker A, Sullivan JM. 2003. Cannabinoid receptor activation differentially modulates ion channels in photoreceptors of the tiger salamander. J. Neurophysiol 89: 2647-2654.
61. Trazzi S, Steger M, Mitrugno VM, Bartesaghi R, Ciani E. 2010. CB1 cannabinoid receptors increase neuronal precursor proliferation through AKT/glycogen synthase kinase-3beta/beta-catenin signalling. J Biol Chem 285: 10098-10109.
62. Vig E, Green M, Liu Y, Yu KY, Kwon HJ, Tian J, Goebl MG, Harrington MA. 2001. SIMPL is a tumor necrosis factor-specific regulator of nuclear factor-kappaB activity. J Biol Chem 276: 7859-7866.
63. Walter L, Stella N. 2003. Endothelin-1 increases 2-arachidonoyl glycerol (2-AG) production in astrocytes. Glia 44: 85-90.
64. Wei Y, Wang X, Wang L. 2009. Presence and regulation of cannabinoid receptors in human retinal pigment epithelial cells. Mol Vis 15: 1243-1251.
65. Wolf SA, Ullrich O. 2008. Endocannabinoids and the brain immune system: New neurones at the horizon? J Neuroendocrinol 20: 15-19.
66. Wotherspoon G, Fox A, McIntyre P, Colley S, Bevan S, Winter J. 2005. Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons. Neuroscience 135: 235-245.
67. Yazulla S, Studholme KM, McIntosh HH, Fan SF. 2000. Cannabinoid receptors on goldfish retinal bipolar cells: Electron-microscope immunocytochemistry and whole-cell recordings. Visual Neurosci 17: 391-401.
68. Yazulla S. 2008. Endocannabinoids in the retina: From marijuana to neuroprotection. Prog Retin Eye Res 27: 501-526.
69. Zhang P, Martin M, Michalek SM, Katz J. 2005. Role of mitogen-activated protein kinases and NF-kappaB in the regulation of proinflammatory and anti-inflammatory cytokines by Porphyromonas gingivalis hemagglutinin B. Infect Immun 73: 3990-3998.
70. Zhao Q, Wang X, Nelin LD, Yao Y, Matta R, Manson ME, Baliga RS, Meng X, Smith CV, Bauer JA, Chang CH, Liu Y. 2006. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J Exp Med 203: 13-40.